Fmr LLC Veracyte, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Fmr LLC holds 49,441 shares of VCYT stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,441

Previous 11,738 321.2%

Holding current value

$1.85 Million

Previous $260,000 311.92%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$18.86 - $23.55 $711,078 - $887,905	37,703 Added 321.2%	49,441 $1.07 Million
Q1 2024 May 13, 2024	SELL	$21.0 - $29.1 $12,600 - $17,460	-600 Reduced 4.86%	11,738 $260,000
Q4 2023 Feb 13, 2024	BUY	$19.72 - $28.68 $11,634 - $16,921	590 Added 5.02%	12,338 $339,000
Q3 2023 Nov 13, 2023	BUY	$22.33 - $29.92 $27,733 - $37,160	1,242 Added 11.82%	11,748 $262,000
Q2 2023 Aug 11, 2023	SELL	$20.96 - $26.99 $758,248 - $976,390	-36,176 Reduced 77.49%	10,506 $267,000
Q1 2023 May 11, 2023	BUY	$20.58 - $27.89 $6,050 - $8,199	294 Added 0.63%	46,682 $1.04 Million
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $4,455 - $8,712	-291 Reduced 0.62%	46,388 $1.1 Million
Q3 2022 Nov 10, 2022	BUY	$16.58 - $27.9 $153,066 - $257,572	9,232 Added 24.65%	46,679 $775,000
Q2 2022 Aug 12, 2022	BUY	$15.45 - $29.52 $174,909 - $334,195	11,321 Added 43.33%	37,447 $745,000
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $1.07 Million - $2.07 Million	-48,806 Reduced 65.13%	26,126 $720,000
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $3.66 Million - $5.46 Million	-101,416 Reduced 57.51%	74,932 $3.09 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $7.75 Million - $11.5 Million	-217,520 Reduced 55.23%	176,348 $8.19 Million
Q2 2021 Aug 13, 2021	BUY	$32.94 - $56.62 $13 Million - $22.3 Million	393,868 New	393,868 $15.7 Million

Others Institutions Holding VCYT

# of Institutions

270

Shares Held

78.7M

Call Options Held

42.3K

Put Options Held

18.2K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.67B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account